DGAP-News: OXIS International Continues Its Global Product Rollout With the Release of Its New Prograce(TM) Anti-Aging Serum

Oxis International Inc. 

19.07.2012 08:30
---------------------------------------------------------------------------

BEVERLY HILLS, Calif., 2012-07-19 08:30 CEST (GLOBE NEWSWIRE) --
OXIS International, Inc., (OTCBB:OXIS) (Paris:OXI) today announced a major step
in the implementation of its global product launch strategy with the
introduction of its much anticipated Prograce(tm) Anti-Aging Serum
(http://www.prograceyou.com). Prograce is the first of OXIS's luxury skin care
line products to contain its proprietary 'intelligent anti-oxidant' EGT(tm) (99%
pure L-ergothioneine). Dr. Tony Nakhla, 'America's Dermatologist' and author of
the new book 'Skin Commandments - 10 Rules to Healthy Beautiful Skin', has been
advocating the significant benefits of EGT through numerous interviews in many
prominent publications including New Beauty, Ocean, Prevention. 

According to Dr. Nakhla, 'The use of EGT in skin care is of particular value
due to the unique and powerful anti-oxidant/anti-inflammatory effects and
specifically with respect to its impact on protecting the skin from the damages
from sun light. EGT is referred to as the 'intelligent antioxidant' as it is
the only anti-oxidant having a dedicated transport mechanism in the body to
deliver it through the cell membrane and into the mitochondria, the energy
producing area of the cell.' 

OXIS' marketing partner, engage:BDR is again leading the worldwide marketing
program to support OXIS's continuing new product rollouts and has been
developing a comprehensive, full digital, advertising campaign for a pipeline
of OXIS' proprietary EGT(tm) anti-aging personal care products and dietary
supplements. engage:BDR reaches targeted audiences of more than 100 million
monthly through its proprietary advertising network and through mobile and
video advertising. 

David Saloff, OXIS Chairman and CEO stated, 'Initial sales are right on target
and we anticipate that orders for Prograce(tm) will continue to progress as
expected, providing significant and growing revenue for OXIS as additional
products continue to come to market in the coming weeks and months.' 

'This is another major step forward in realizing the full potential of this
unprecedented global opportunity to introduce our proprietary EGT(tm) based
products direct to consumers with the help of our partners at engage:BDR,' Mr.
Saloff continued. 'Their outstanding track record executing on
direct-to-consumer product campaigns and ability to deliver our product message
to a much targeted audience will make for a very successful launch,' Saloff
concluded. 

'OXIS International has demonstrated tremendous expertise in product
development with its EGT product line which we're extremely excited to deliver
to the market,' said Ted Dhanik, president, engage:BDR. 

About OXIS International, Inc.

OXIS International, Inc. develops technologies and products to research,
diagnose, treat and prevent diseases of oxidative stress/inflammation
associated with damage from free radical and reactive oxygen species (ROS). The
company holds the exclusive patent to manufacture EGT, which has received full
GRAS (safety) approval. In addition the company holds the rights to several
therapeutic classes of compounds in the area of oxidative stress, including
EGT(TM) (99% pure L-ergothioneine), known as the intelligent antioxidant. 


         CONTACT: David Saloff
         424-248 2311
         David@Oxis.com
         www.oxis.com
News Source: NASDAQ OMX



19.07.2012 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Oxis International Inc.
              
               
              United States
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         US6918294025
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------